Tsinghua-Backed Lingxin Intelligence Completes Angel Funding Round to Advance AI-Powered Mental Health Solutions

VCBeatLearned at the earliest opportunity: Recently, Beijing Lingxin Intelligent Technology Co., Ltd. (hereinafter referred to as “Lingxin Intelligence”), incubated by the Department of Computer Science and Technology at Tsinghua University, announced the completion of its angel financing round, which was exclusively invested by Tsinghua alumni.

Since its inception, Lingxin Intelligence has been dedicated to applying the most advanced artificial intelligence technologies to digital diagnostic and therapeutic services for mental health. By establishing an advanced AI-based digital therapeutics system, it provides high-quality, low-cost, personalized, and round-the-clock emotional support, psychological counseling, and intervention solutions for clinical patients and the broader population with suboptimal mental well-being, thereby delivering more scientific and efficient mental health services to users.

It is understood that Lingxin Intelligence was founded by Professor Huang Minlie of Tsinghua University. The founding team members hail from prestigious academic and research institutions, including Tsinghua University, Peking University, and Beijing Normal University. The team has published over 100 papers in top-tier international conferences and journals, receiving more than ten Best Paper Awards or nominations. Their achievements have been honored with the First Prize of the Wu Wenjun Artificial Intelligence Science and Technology Progress Award, and their work has been supported by key projects of the National Natural Science Foundation of China and the National Science Fund for Distinguished Young Scholars.

Since its inception, Lingxin Intelligence has been committed to the mission of “providing personalized mental health solutions and building a better mental world.” Focusing on empowering innovation in the field of mental health, the company seeks more cost-effective and efficient intervention strategies by leveraging the integration of AI and mental healthcare, thereby delivering maximum therapeutic value to users. Currently, its most advanced project is AM-D01, targeting persistent depressive disorder. This project is based on a proprietary intervention system that combines AI with cognitive behavioral therapy (CBT) and is undergoing a series of clinical trials and studies across diverse populations. Meanwhile, Lingxin Intelligence is actively developing intervention programs for multiple indications.

Regarding the completion of this round of financing, Professor Huang Minlie, Founder of Lingxin Intelligence, stated, “The latest epidemiological surveys indicate that individuals with mental disorders account for approximately 16–17% of the total population. Mental health is a core issue we face, yet China has fewer than 50,000 professional psychological counselors.”Engaged in full-time and part-time work in the psychological counseling industry, psychiatrists are even scarcer. This significant gap between supply and demand can be bridged by artificial intelligence technologies and corresponding products. If natural language processing is the crown jewel of artificial intelligence, then AI technology in the field of mental health is the most dazzling facet of that jewel, carrying profound social significance and offering immense commercial potential. Although we face numerous technical challenges, our team began relevant research several years ago and has accumulated robust technical expertise, including our developed affective dialogue technology and emotional support dialogue systems.

“Over the past year, digital therapeutics have garnered significant attention from both the pharmaceutical industry and capital markets, and our fundraising efforts have proceeded smoothly. This round of financing will help accelerate preclinical research on the Lingxin Depression Spectrum series, while also providing strong support for the launch of several subsequent projects, the building of a high-caliber talent team, and facility expansion. I believe that with the support of our investors and the dedication of the Lingxin team, we will fully unlock our R&D potential and make greater contributions to the field of mental health!”

It is reported that Lingxin Intelligence is currently raising its Pre-A round of financing. In the future, Lingxin Intelligence will continue to deepen its engagement in the field of mental health.To provide patients with more effective treatment options that offer higher adherence.